Development of a Regioselective Synthetic Strategy and Cytotoxicity Examination of Alkoxy-Substituted Phenazine Derivatives That Disrupt G‑Quadruplex Structure Authors: Paweł Ręka, Jakub Glac, Agata Głuszyńska, Jarosław Grolik, Magdalena Obłoza, Katarzyna Ostrowska Published: 2026 ABSTRACT The alkoxy derivatives of phenazin-2­(10H)-one and 2-aminophenazine were synthesized by applying the regioselective procedure, which provides one isomer to be formed exclusively. The obtained compounds bear up to four different substituents in designed positions, extending the versatility of the previously reported procedure for the synthesis of alkoxy-substituted phenazine derivatives. The obtained 2-aminophenazines and phenazin-2­(10H)-ones, as well as other alkoxy-substituted phenazines and N-alkyl phenazinium salts investigated previously, were tested in cell culture experiments against the 4T1 cell linemurine mammary carcinoma, and the Caco-2 cell linehuman colorectal adenocarcinoma. Phenazin-2­(10H)-one (5d) and N-alkyl phenazinium salts (12a and 12b) with significant cytotoxicity, IC50 < 10 μM, were identified in both cell line assays. For selected cytotoxic compounds, cell experiments were repeated against the NMuMG cell linea murine mammary normal cell line, to determine the selectivity index, where the highest value was found to be approximately SI ∼2 for phenazin-2­(10H)-one 5a. Representative examples of the obtained compounds: phenazin-2­(10H)-one (5d), 2-aminophenazine derivatives (8b, 9a, and 10ba), and 2,3-dialkoxyphenazine (6a) were investigated for their interaction with the G-quadruplex formed by the DNA sequence derived from the NHE III1 promoter region of the c-MYC oncogene. Destabilization of the investigated DNA structure by all of the tested compounds was confirmed by UV–vis spectrophotometry and CD spectroscopy. Introduction Fordos isolated pyocyanin, a blue pigment containing a phenazine scaffold, from the culture of Pseudomonas aeruginosa in the 19th century. Later, the discovery of pyocyanin’s antibiotic activity sparked interest in pharmacological applications of phenazine derivatives. Advances in organic chemistry have provided synthetic methods for new phenazines and their further functionalization, introducing different functional groups and heteroatoms. For now, at least several hundred bioactive phenazine derivatives have been investigated and therein compounds with antimicrobial, antifungal, antiviral, antitumor, and insecticidal activities were described. Among phenazines, the 2,3-dialkoxy-substituted derivatives are not well investigated, and the bioactivity of only a few examples has been described in the literature. − Therein, 7,8-dialkoxy derivative of phenazine-2-carboxamide (Figure A), which was investigated both in vitro and in vivo against the human pancreatic cancer, MiaPaCa-2 cell line. The anticancer activity of phenazine derivatives is usually caused by topoisomerases inhibition and DNA intercalation. For the investigated 2,3-dialkoxyphenazines, DNA intercalation was not observed in the ethidium bromide exclusion assay, suggesting a different cytotoxicity mechanism for these compounds. The N-substituted phenazinium salts have a strong affinity toward negatively charged nucleic acids; therefore, they were applied, i.a., in DNA photocleavage. Compounds bearing N-substituted phenazin-2­(10H)-one scaffold occur in nature, which are produced by microorganisms, especially Pseudomonas and Streptomyces. Among others, endophenazine B isolated from Streptomyces anulatus exhibits weak herbicidal activity against Lemna minor, and isolated from Streptomyces diastaticus phenazinolines, wherein phenazinolin A and B exhibit appreciable cytotoxicity and antibiotic effects. The first known synthetic compound with phenazin-2­(10H)-one scaffold is aposafranone, described by Kehrmann in 1896. For now, similar phenazinone derivatives (Figure B) were found to be active against the lung cancer cell lineA549 in submicromolar concentrations and with various selectivity in comparison to the normal cell line MRC-5. The antitumor activity of benzo­[a]­phenazine-5­(7H)-ones, bearing phenazin-2­(10H)-one core, was investigated on various human cancer lines, and their cytotoxicity by inhibition of topoisomerases I and II was confirmed. Selected examples of 2,3-dialkoxyphenazine with anticancer activity (A), phenazin-2­(10H)-one derivatives cytotoxic against A549 cancer cell line (B), and 2-aminophenazine derivatives cytotoxic against Caco-2 cell line in hypoxia (C). The relatively new strategy of targeting DNA G-quadruplexes (G4s) by small molecules has shown promising effects in cancer therapy in clinical trials as well as several other health-related diagnostic applications. The phenazine derivatives investigated as G4s ligands showed significant stabilization of the hTELO sequence, with noticeably lower values for other G4s and duplex DNA, which was confirmed by lower telomerase activity in cells in the presence of the compound. G-quadruplexes DNA (G4s DNA) is a biologically important and, in consequence, intensely studied type of noncanonical single- or multistranded nucleic acid structures. G-quadruplex DNA (G4 DNA) is a structure discovered in guanine-rich regions of the human genome, such as human telomeres, as well as in the promoter regions of some oncogenes, including c-MYC, c-KIT, Bcl-2, or RET. G4s DNA has become a molecular target in the search for, among others, anticancer, antiviral, and gene expression regulation drugs, as well as for diseases related to neurodegeneration. They are composed of stacked four guanosine nucleobases (G-tetrads) that are stabilized by Hoogsteen-type hydrogen bonds in the presence of certain alkali-metal cations (e.g., Na+ and K+) and can be stabilized by small organic ligands. Most compounds that interact with G-quadruplexes DNA have been identified as stabilizers of these structures, while there are still few literature reports of compounds capable of destabilizing G4s. Thus, finding a new group of G4-disrupting small molecules could increase the therapeutic potential of G-quadruplexes by regulating their biological function. The 2-aminophenazine scaffold is common in natural and synthetic compounds. Amino group present in these compounds is an auxochrome, which bathochromically shifts the absorption and emission spectra, providing application of many 2-aminophenazines, especially N-substituted amines as dyes or stains. , One of the first 2-aminophenazine derivatives, the phenosafranin known from 1878, was recently investigated for targeted cancer therapy and imaging. Other compounds containing the 2-aminophenazine scaffold, in which their N 5,N -dioxides (Figure C) were examined for selective cytotoxicity against the Caco-2 cell line in hypoxia; however, compounds were tested as an isomer mixture obtained via the Beirut reaction. Derivatives of 2,3-diaminophenazine substituted with long alkyl or alkoxyl groups were investigated as anticancer agents, against castration-resistant prostate cancer, whose mechanism of action works by disruption of Hsp27-eIF4E interaction. Derivatives of 2,3-diaminophenazine were also investigated as promising agents against SARS-CoV-2 virus, also with noticeable antibacterial activity against Streptococcus pneumoniae, Escherichia coli, and K. pneumoniae in the concentration around 30 μg/mL, similar to tetracycline used as a reference compound. The known synthetic strategies for phenazin-2­(10H)-one scaffolds are based on the condensation of N-substituted o-phenylenediamines with hydroxybenzoquinones, which were applied in the synthesis of fused heterocycles. The regioselective synthesis of isodiphenylfluorindone derivatives was achieved by oxidative cyclization of N-substituted 2,2′-diaminodiphenylamine derivatives and then deprotection of the benzyl group with hexafluoroisopropanol. Oxidation of N-phenylbenzene-1,2-diamine with air in the presence of ferric chloride in DMF also gives phenazin-2­(10H)-one; however, only a low yield was reported. New approach in the synthesis of phenazin-2­(10H)-one is based on [3 + 3] annulation of enaminones with o-fluoronitrobenzenes, which gives the product in one chemoselective reaction step with moderate yield. 10-Methylphenazin-2­(10H)-one was obtained by demethylation reaction of 5,10-dimethyl-5,10-dihydrophenazine with hydrobromic acid in DMSO. The reaction gives products with low to good yields, highly dependent on substrate molecular structure. Some highly fluorinated phenazine derivatives give phenazin-2­(10H)-one core product of hydrolysis, which opens a route for compounds impossible or difficult to obtain in other ways, as reported. The synthetic strategies developed in the 1960s by Holliman and Gray established protocols for various phenazines previously identified in microorganisms, wherein several 2-aminophenazines were described in a series of publications. Although there are a lot of synthetic strategies suitable for the synthesis of 2-aminophenazines, , this topic is still expanding with new methods reported recently. In our research, we have adapted Eckert-Steiner’s synthetic method for the preparation of 2-aminophenazines, which, to the best of our knowledge, has not been reported so far. The wide range of applications of phenazine derivatives implies a demand for new synthetic strategies that can give desired products with high yields and provide routes for their targeted functionalization and derivatization. In this research, we have developed a new procedure for the selective and efficient synthesis of nonsymmetrically alkoxy-substituted derivatives of phenazin-2­(10H)-one, phenazin-2-ol, and 2-aminophenazine, which is a continuation and complement of the previously reported alkoxy-substituted phenazines and phenazinium salts synthetic approach. The presented synthetic protocol provides a route for phenazine derivatives substituted with multiple electron-donating groups (up to four), which significantly influence their spectroscopic properties, resulting in highly fluorescent compounds that are responsive to changes in solution pH. As described in the introduction, the biological activity of alkoxy-substituted phenazine derivatives was studied only on several examples, which put this field in our interest. In this research, we investigated the potential anticancer activity of the obtained compounds in experiments in vitro against 4T1 and Caco-2 cell lines to identify derivatives promising for further research. The obtained compounds were also investigated as potential G-quadruplex DNA ligands because of their planar aromatic structure, which can be selectively modified with the desired functional groups. Results and Discussion Synthesis of Phenazin-2­(10H)-ones 5a–5d and 2-Hydroxyphenazine 3a For the synthesis of 3-alkoxy and 3,7,8-trialkoxy-substituted phenazin-2­(10H)-ones and 2-hydroxyphenazines, we adapted a previously reported regioselective synthesis of 4,5-dialkoxy-2-nitroanilines for the preparation of compounds substituted with a benzyloxy group (OBn) at C5 (1a and 1b, Scheme ). The bis­(2-nitrophenyl)­amine derivatives (2a–2d) were obtained via Buchwald–Hartwig amination, using 2-nitroanilines (1a and 1b), which provided R1, R2 = OBn, R3, and R4 to be placed at specific, designed positions. Buchwald–Hartwig coupling provides reaction regioselectivity with high yields and is also tolerant of a broad scope of possible substrates. In this research, 1-bromo-2-nitrobenzenes substituted with an electron-withdrawing trifluoromethyl group, an electron-donating alkoxy group, and a sterically hindered tert-butyl group were successfully utilized in the synthesis. Reduction of the obtained compound 2a with sodium borohydride on a palladium catalyst results in reduction of the nitro groups to amines, as well as elimination of the benzyl group, yielding a hydroxyl substituent instead. Synthesis of 2-Hydroxyphenazine 3a and N-Alkyl Phenazin-2­(10H)-ones 5a–5d Cyclization of this intermediate to phenazine is provided by mild oxidant ferric chloride, resulting in the formation of phenazin-2-ol derivative 3a (Scheme ). The described synthesis is based on the protocol described in detail and discussed in our previous research. , Compounds 2a–2d can be easily converted into 4a–4d with high yields via alkylation with an alkyl iodide. In this research, compounds 4a, 4c, and 4d were obtained by using a protocol that utilizes sodium hydride as a base. For compound 4b, a different method was also tested using cesium carbonate, which provided milder basic conditions. In several batches of 4b obtained with sodium hydride (the same protocol as 4a, 4c, and 4d) and cesium carbonate, reactions performed with cesium carbonate had higher yields and a much better repeatability. The additional electron-withdrawing effect of the trifluoromethyl group on substrate 2b is the most probable reason for the lower yields (<40%) and greater tar formation observed in the preliminary experiments with sodium hydride, used as a base. These problems were not observed for substrates 2a, 2c, and 2d substituted with electron-donating groups, which were obtained in good yields (Scheme ) and did not form significant quantities of byproducts that could cause purification issues. The reduction-oxidative cyclization reaction in the case of 4a–4d results in the formation of phenazin-2­(10H)-one derivatives 5a–5d (Scheme ). The catalytic reduction of compounds 4a–4d results in the elimination of the benzyl substituent and formation of compounds (5a–5d), which are nonionic enaminones rather than zwitterions (as shown in Scheme ), as confirmed by detailed 1H and 13C NMR spectroscopy (NMR spectra of 5a–5d are contained in SI). This synthetic approach provides a reliable method of regioselective synthesis of N-alkyl phenazin-2­(10H)-ones, which is an extension of N-alkyl phenazinium salt synthesis described in our previous research. In this method, compounds with desired substituents can be designed via the utilization of regioselectively synthesized 4,5-dialkoxy-2-nitroanilines and 4,5-dialkoxy-1-bromo-2-nitrobenzenes. Postsynthetic Modification of Phenazin-2-ol Derivative 3a The phenazin-2-ol 3a obtained in this research can be easily transformed into an O-alkyl derivative (2,3-dialkoxyphenazine), which opens a route to compounds that cannot be synthesized directly by using the described protocol due to the influence of the substituent on one of the reaction steps or the instability of the side chain itself during the process. This synthetic approach was developed in response to the need to introduce alkoxy substituents that bear additional amine groups into the investigated phenazine. The synthesis of the investigated compound (6a), during the two-step procedure (Scheme a), results in the formation of tars and byproducts in multiple tries and under modified conditions. All performed experiments suggest that the presence of the N,N-dimethyl-2-aminoethoxy substituent obstructs oxidative cyclization of bis­(2-aminophenyl)­amine to phenazine, most probably by the formation of additional interaction with the ferric ion. To overcome this limitation and establish a route for more phenazine derivatives, a method of phenazin-2-ol alkylation was developed (Scheme b). This path provides a successful synthesis of 6a with a good yield (98% of 6a from 3a, 62% of 3a formation from 2a), and further extension of this protocol is currently under investigation. Synthetic Route for Compound 6a Synthesis of 2-Aminophenazine Derivatives 8a–8d and 9a The further extension of the developed synthetic protocol provides a method for regioselective synthesis of alkoxy derivatives of 2-aminophenazine. 7,8-Dialkoxy-2-aminophenazines were obtained from bis­(2-aminophenyl)­amine derivative, substituted with additional nitro-group at C4 position (Scheme a, 7a–7d). All the nitro-groups present in compounds 7a–7d are reduced under catalytic conditions to amines. In the oxidative cyclization with ferric chloride, two of the amine groups (at C2, C2′) participate in the formation of the pyrazine ring, and one (at C4) remains unreacted, which yields 2-aminophenazine in this protocol. Nonselective oxidation of the remaining amine group might be one of the reasons behind lower yields for those reactions and more tar formation than observed for phenazines investigated in previous research. , Nevertheless, the nonquantitative isolation of the final product due to its extraction from a high volume of water is supposed to have a major impact on reaction yield, as compounds with increasing hydrophilicity were observed to result in lower yields as follows: 8c (82%), 8b (80%), 8a (67%), and 8d (46%). The direct substrates (7a–7c) for the synthesis of 2-aminophenazine (8a–8c) were obtained from 4,5-dialkoxy-2-nitroanilines via arylation with 2,4-dinitro-1-chlorobenzene under basic conditions, as described in the Methods section (Scheme a). Synthesis of 2-Aminophenazine Derivatives 8a–8c and 9a 2-Aminophenazine 9a was obtained by modification of the 4,5-dialkoxy-2-nitroaniline substrate. 4,5-Dibutoxy-2-nitroaniline in the reaction with 3-aminopropanol, according to a procedure analogous to previously investigated, results in the formation of 4-butoxy-6-nitrobenzene-1,3-diamine derivative 1c. In this reaction, the product with an aromatic ring substituted with an amine (1c) is formed almost exclusively, although substitution via an oxygen atom was expected to form competitively. Compound 2e was obtained from 1c through the Buchwald–Hartwig coupling and after reduction and oxidative cyclization yields 3,7,8-trialkoxy-2-aminophenazine 9a. Compounds 2e and 9a were obtained with moderate to good yields, 62% and 77%, respectively, although no protection groups were applied to the NH and OH groups of the side chains in either step. Postsynthetic Modification of 2-Aminophenazine Derivatives 8a–8c The amino group present in the investigated compounds opens a route for their further modification to obtain a wide range of derivatives with better optimized properties and activity. For the compounds’ modification, reactions of acylation, alkylation, and catalytic arylation were investigated. The 2-aminophenazines 8a and 8b, in the reaction with diluted acetic anhydride, form amides 10aa and 10ba (Scheme ) with good yields, 88% and 70%, respectively. The reaction was conducted in the 1,4-dioxane solution, as in the preliminary research, this method results exclusively in a product of monoacylation, and the reaction conducted without solvent results in the formation of a mixture of acylation products at high temperatures and incomplete conversion at RT. The 2-aminophenazines 8a–8d, under storage in an air atmosphere, can partially oxidize, which results in the formation of a tar film on the samples. Compounds 10aa and 10ba with an amino group protected as an amide are stable under storage and resistant to oxidation. Preliminary experiments of 8a alkylation with ethyl iodide in various conditions always resulted in a mixture of different, non-isolated compounds. Reaction of 10aa with ethyl iodide results in the formation of one compound, monoalkylated amide 10ab, with good yield (Scheme ). This reaction opens the route of selective modification of the obtained 2-aminophenazines via alkylation, which is currently under investigation. Postsynthetic Modification of 2-Aminophenazines 8a–8c Compounds 8a and 8c were also tested in the Buchwald–Hartwig coupling reaction, which demonstrates the compounds’ reactivity and the possibility of further modification. Compounds 10ac and 10cc were obtained in the reaction of 1-bromo-3,5-dimethylbenzene with 8a and 8c, respectively (Scheme ). Both compounds were obtained in the same synthetic protocol with a good yield. Further investigation of the Buchwald–Hartwig amination application was the coupling of 8c with 1,3-dibromobenzene in a 2:1 ratio. This reaction gives compound 10cd (Scheme ) with moderate yield, among easily separated byproducts. Compound 10cd is the preferred product of the reaction even if access of 1,3-dibromobenzene (2 equiv) was used. For this reaction, the intermediate, which is the product of 1:1 condensation, is more reactive in Buchwald–Hartwig amination than the initial 1,3-dibromobenzene due to the increased electron density of the aromatic ring caused by the electron-donating amine substituent. Synthetic protocols for all compounds are described in detail in the Methods Section. UV–Vis and Fluorescence Data of Investigated Compounds in Solution The spectroscopic properties of N-methylphenazin-2­(10H)-one and 2-aminophenazine derivatives obtained in this study were characterized by UV–vis absorbance and fluorescence measurement. The spectra were recorded in chloroform and acetonitrile as nonpolar and polar solvents, respectively. The fluorescence quantum yield (Φ f ) was also determined in both solvents. For N-methylphenazin-2­(10H)-ones and 2-aminophenazines, shift in absorption and emission maxima and changes in fluorescence Φ f were observed in response to solution acidification. The impact of pH changes on the spectroscopic properties of selected compounds was investigated in detail, using phenazinone 5d and 2-aminophenazine 9a as examples. A fluorescence acid–base titration experiment was conducted for these compounds. The results of spectroscopic measurements are collected in Table S1 in the Supporting Information. Among 15 investigated compounds, there are 2 of 4 phenazin-2­(10H)-one derivatives and 5 of 11 2-aminophenazines, which have Φ f > 0.10. Among a series of phenazinones (5a–5d), all compounds have emission maxima at similar wavelengths (∼550 nm), but there is a strong impact of substituents on fluorescence quantum yields. Compound 5b is substituted with an electron-withdrawing trifluoromethyl group, has Φ f = 0.013, 5a is substituted with a tert-butyl group and has Φ f = 0.022, and phenazinones substituted with electron-donating alkoxy-groups (5c, 5d) have Φ f = 0.13 and Φ f = 0.15, respectively, in chloroform. The N-substituted phenazin-2­(10H)-ones investigated in these studies can be described by two resonance structures: a zwitterion with a cation on the pyrazine ring and an anion on the oxygen atom, and a second structure, phenazinone, which has no formal charges, as illustrated in Scheme . The neutral phenazinone structure is dominant under neutral or basic conditions, whereas under acidification, the compound is protonated and forms the 3-hydroxyphenazinium ion (Scheme ). The strongly downfield-shifted signals (178.2–176.2 ppm) in 13C NMR spectra of 5a–5d unequivocally confirm the presence of a carbonyl group in the investigated 10-methylphenazin-2­(10H)-one derivatives (compound characteristics and NMR spectra are contained in the Supporting Information). Additionally, on the representative example of 5d, the 1H NMR acid titration was investigated. For the titration experiment, the 5d solution (5 mM) in CDCl3 was prepared and acidified with 0.5, 1, and 2 equiv of methanesulfonic acid (MsOH), collecting the 1H NMR spectrum each time. The obtained titration spectra and the spectrum of the 5d protonated form, with assigned molecular structure, are contained in the Supporting Information. During the acidification, the signals from protons at phenazine core (H1, H4, H6, and H9) are downfield shifted, which places them in a similar range as in the case of previously investigated N-alkyl phenazinium salts (i.a., 12a). The strong downfield shift also considers the proton signal of the methyl group at the phenazine nitrogen atom (H10b), which changes from 3.76 to 4.67 ppm, similarly as for the phenazinium salts. The change of pH significantly influences the electronic properties of the phenazine core of the compound, thereby resulting in varying optical properties. The impact of protonation was observed for all investigated phenazinones (5a–5d) in acetonitrile solution with the addition of methanesulfonic acid. The addition of acid shifts compounds’ absorption and emission maxima hipsochromically by about 50 nm and significantly increases fluorescence quantum yields. For the strongly fluorescent compounds 5c and 5d, the change from Φ f = 0.14 and 0.095 to 0.39 and 0.46, respectively, was observed. For phenazinone 5d, fluorescence titration gave an equilibrium point at an apparent pH of 4.10 in acetonitrile, indicating that alkoxy-derivatives of phenazin-2­(10H)-ones are stronger bases than 2,3,7,8-tetraalkoxyphenazines, e.g., 11a, which in our previous study showed an equilibrium point at an apparent pH of 1.65. The UV–vis absorption and emission spectra of phenazine-2-one 5d, in acetonitrile solution, are presented in Figure . Resonance Structures and Acid–Basic Equilibrium of 10-Methylphenazin-2­(10H)-one Comparison of absorption and fluorescence spectra of 5d in acetonitrile solution with and without the addition of methanesulfonic acid. Among the investigated 2-aminophenazine derivatives, the primary amines 8a, 8b, 8c, 8d, and alkyl-substituted secondary amine 9a exhibit intense fluorescence with Φ f > 0.10. All of them have absorption maxima near 430 nm and fluorescence maxima at ∼520 nm and ∼495 nm for 9a in chloroform. The change of solvent to acetonitrile results in a weak bathochromic shift of absorbance maxima for 8a–8d, while emission maxima are not influenced significantly. For primary amines, 8a–8d fluorescence quantum yield is higher in acetonitrile compared to chloroform, with differences of 0.01 to 0.05 (for details, see Table S1). For 9a, the absorption maximum is shifted hipsochromically by 5 nm, and the emission maximum is shifted bathochromically by 4 nm in acetonitrile solution compared to chloroform. The fluorescence quantum yield decreases in acetonitrile, from 0.28 to 0.24 for 9a. The pH titration of 9a in acetonitrile showed an equilibrium point at an apparent pH of 3.60, indicating that 9a is a weaker base than 5d. The absorption maximum of 9a is shifted bathochromically by 72 nm in acetonitrile solution in the presence of acid, while the emission maximum is shifted bathochromically by 56 nm. The change in 9a spectra under acidification is shown in Figure . Detailed spectroscopic experiments, including fluorescence pH titration, were conducted only for 9a, as 8a–8d are unstable and undergo photodegradation during prolonged, repetitive measurements. Comparison of absorption and fluorescence spectra of 9a in acetonitrile solution with and without the addition of methanesulfonic acid. In this research, the impact of postsynthetic modification of 2-aminophenazines on the compounds’ spectroscopic properties was investigated for amides (10aa and 10ba), alkylamide (10ab), and N-aryl derivatives (10ac, 10cc, and 10cd). The formation of acetamides from 2-aminophenazines 8a and 8b results in the formation of amides 10aa and 10ba for which absorption maxima are shifted hipsochromically by 29 and 31 nm, respectively. Emission maxima are shifted hipsochromically by 71 and 81 nm, respectively. Fluorescence quantum yields are generally lower for amides compared to 2-aminophenazines and have changed from 0.29 for 8a to 0.092 for 10aa, and from 0.14 for 8b to 0.019 for 10ba in chloroform. Spectra of 8a and 10aa in chloroform are compared in Figure . Compound 10ab obtained by alkylation of 10aa has similar absorption and emission maxima but a lower Φ f of 0.049 in chloroform. Comparison of absorption and fluorescence spectra of 2-amiophenazine 8a and amide 10aa in chloroform solution. All of the investigated 2-aminophenazines functionalized with an aryl substituent (10ac, 10cc, and 10cd) are weakly fluorescent with Φ f < 0.10. The absorption maxima are bathochromically shifted by about 30 nm in all cases regarding the corresponding substrates 8a and 8c. The fluorescence spectrum of 10cc is bathochromically shifted by 27 nm compared to 8c. In the case of 10cd, the spectrum is shifted by 17 nm. Nevertheless, the aryl-substituted 2-aminophenazines are weakly fluorescent; their complex spectra suggest interesting optical properties that will be investigated in detail in future research. Comparison of 2-aminophenazine derivatives 8c, 10cc, and 10cd is shown in Figure . Comparison of absorption and fluorescence spectra of 2-amiophenazine derivatives 8c, 10cc, and 10cd in chloroform solution. Examination of Compounds’ Cytotoxicity and Selectivity against Cancer Cell Lines The selected representative compounds of each series were investigated in cell culture experiments. A decrease in cell viability compared to the control was determined using the MTT assay, and the inhibition concentration (IC50) was calculated to compare the cytotoxicity of the investigated compounds. Preliminary experiments, performed at 50 μM concentrations, were used to select compounds for detailed examinations. The cytotoxicity of selected compounds was investigated at concentrations ranging from 0.1 to 50 μM against the 4T1 cell line (murine mammary carcinoma) after 24 and 48 h of incubation. The experiment was repeated for the most interesting compounds against the Caco-2 cell line (human colorectal adenocarcinoma) and the NMuMG cell line (murine normal, epithelial-like cells). The selectivity of the compounds investigated against cancer cells was calculated as the selectivity index (SI), defined as the ratio of IC50 values for the NMuMG and 4T1 cell lines. In addition to compounds obtained in this research, two 2,3-dialkoxyphenazines, , and two N-alkyl phenazinium salts, from our previous works, were also examined. The molecular structures of those derivatives are shown in Figure . Compounds were obtained as reported previously. , Alkoxy-derivatives of phenazine and N-alkyl phenazinium salts. All experiments were done in triplicate. The determined IC50 and SI values for each cell line after incubation with the investigated compounds are collected in Table . The preliminary screening of representative compounds enabled the identification of compounds exhibiting noticeable cytotoxicity; however, several tested compounds did not cause loss of viability in 4T1 or Caco-2 cells at 50 μM (Table ). Among the investigated compounds, N-alkyl derivatives of phenazin-2­(10H)-one (5a and 5d) and phenazinium salts (12a and 12b) exhibit the highest cytotoxicity against all tested cell lines. The lowest IC50 value of <10 μM for these compounds makes them promising candidates for further research. For both groups, there is a significant difference in biological activity depending on the substituents. Compounds 5d and 12a bearing four alkoxy groups have noticeably higher cytotoxicity than 5a and 12b bearing two alkoxy substituents and a tert-butyl group. However, the less cytotoxic derivatives 5a and 12b are more selective against the cancer cell line 4T1 in comparison to the normal cell line NMuMG (Table ). For the phenazin-2­(10H)-one derivatives, the compound substituted with a trifluoromethyl group (5b), exhibits no cytotoxicity at 50 μM concentration in preliminary experiments. Those initial examinations suggest a strong impact of compounds’ functional groups and substitution patterns on their activity, which needs to be investigated in future research. Among 2-aminophenazines, most of the investigated compounds exhibit no cytotoxicity in preliminary studies. One of the compounds, 8c, has a very weak effect on the investigated cell lines, with an IC50 beyond the tested range of 50 μM. 1Cytotoxicity of Investigated Compounds against 4T1, Caco-2, and NMuMG Cell Lines 4T1 IC50 [μM]Caco-2 IC50 [μM]NMuMG IC50 [μM] compound R 1 R 2 R 3 R 4 24 h48 h24 h48 h24 h48 hSI 5a -O(CH2)3CH3 --H-tBu>5014.4 ± 2.232.0 ± 1.317.9 ± 0.547.2 ± 9.327.2 ± 2.61.9 5b -O(CH2)3CH3 --CF3 -H->50 ->50 ->50 - 5d -O(CH2)3CH3 --OCH2CH3 -OiBu35.9 ± 4.511.1 ± 1.617.3 ± 0.97.3 ± 0.430.1 ± 2.211.7 ± 0.91.1 6a -O(CH2)3CH3 -(CH2)2N(CH3)2 -H-tBu21.7 ± 1.317.8 ± 0.825.9 ± 1.315.4 ± 0.921.5 ± 3.214.9 ± 0.90.8 9a -O(CH2)3CH3 -NH(CH2)3OH-OCH2CH3 -OiBu>50>5019.6 ± 4.410.4 ± 1.7>50>50- 8b -OCH2CH3 -OiBu-NH2 -H->50 ->50 --- 8c -O(CH2)5CH3 -O(CH2)5CH3 -NH2 -H>50>50-->50>50- 10ba -OCH2CH3 -OiBu-NHAc-H->50 ->50 --- 10ac -OCH2CH3 -OCH2CH3 -NH(3,5-diMeC6H3)-H->50 --->50 - 10cc -O(CH2)5CH3 -O(CH2)5CH3 -NH(3,5-diMeC6H3)-H->50 --->50 - 10cd -O(CH2)5CH3 -O(CH2)5CH3 1,3-di(NH−) C6H4 -H->50 --->50 - 11a -O(CH2)5CH3 -OiBu-OCH2CH3 -OCH3 ->50 ->50 --- 11b -O(CH2)7CH3 -OiBu-H-tBu->50 ->50 --- 12a -O(CH2)5CH3 -OiBu-OCH2CH3 -OCH3 7.3 ± 0.86.4 ± 1.016.7 ± 0.93.7 ± 0.411.3 ± 1.66.6 ± 1.21.0 12b -O(CH2)5CH3 -OiBu-H-tBu13.2 ± 6.610.2 ± 0.421.5 ± 1.49.8 ± 0.814.9 ± 6.214.1 ± 1.11.4aThe compound was excluded from detailed experiments after preliminary studies.bSI was calculated from the IC50 values for NMuMG and 4T1 cell lines after 48 h of incubation. “-” - not applicable, or not investigated. Cytotoxicity of Investigated Compounds against 4T1, Caco-2, and NMuMG Cell Lines The compound was excluded from detailed experiments after preliminary studies. SI was calculated from the IC50 values for NMuMG and 4T1 cell lines after 48 h of incubation. “-” - not applicable, or not investigated. Compound 9a has a weak effect on 4T1 and NMuMG cell lines; however, against the Caco-2 cell line, it exhibited noticeable cytotoxicity with an IC50 value of 10.4 μM after 48 h of incubation. The analysis of viability changes in response to 9a concentration for the 4T1 and Caco-2 assays shows a nonlinear response with flattening at higher concentrations, which may suggest that the compound interacts with a specific molecular target. Compound 11b was tested against the LoVo cancer cell line (human colon adenocarcinoma) in our previous study. This compound has a weak cytotoxic effect against the investigated LoVo cell line, however, in tests against 4T1 and Caco-2 cell lines, it does not have noticeable activity at 50 μM concentration. In this research, we investigated compound 6a, which bears a tert-butyl group as 11b, but has shorter alkoxy substituents, an N,N-dimethylaminoethoxy group at the C3 position. Compound 6a exhibits general cytotoxicity against all investigated cell lines with IC50 close to 15 μM after 48 h of incubation, without significant differences among them (Table ). The results of the cell experiments confirmed the utility of the developed synthetic procedure for the preparation of biologically active compounds, including alkoxy derivatives of phenazines, phenazin-2­(10H)-ones, and N-alkyl phenazinium salts. Details of the cell experiments are provided in the Methods section, and charts of cell viability for IC50 determination are provided in the Supporting Information. Investigation of the Impact of Compounds on the Stability of c-MYC G-Quadruplex DNA We extended our studies on the biological activity of selected new phenazine derivatives to include interactions with DNA. We selected a DNA G-quadruplex formed on a sequence corresponding to the promoter region of the c-MYC oncogene NHE III1 as our molecular target. The selected oligonucleotide is a 22-mer wild-type, guanosine-rich sequence that forms a parallel intramolecular G-quadruplex in physiological potassium ion solution. , Of all the proto-oncogenes, c-MYC is the most thoroughly studied and best characterized, and overexpression of c-MYC is associated with a wide range of human cancers, including lung, breast, colon, cervical, and leukemia. In the following studies, we report the interactions of phenazine derivatives 5d, 6a, 8b, 9a, and 10ba with the G-quadruplex c-MYC using UV–vis spectrophotometry and circular dichroism spectroscopy. The likely mode of ligand binding is terminal stacking on terminal G-tetrads due to the planar shape of the phenazine skeleton. In our research, we used UV–vis spectroscopy in two ways: in spectrophotometric titration experiments to determine ligand binding mode and to calculate the binding constants, and also to study the thermal stability of the G-quadruplex in the presence of ligands. In the latter case, the obtained data were used to generate melting curves and thermodynamic calculations. An absorption titration experiment was performed to investigate the affinity of each ligand toward the c-MYC G-quadruplex structure. UV–vis spectra of the phenazine derivatives 5d, 6a, 8b, 9a, and 10ba in the long-wavelength range from 320 to 650 nm with increasing concentrations of the G4 are illustrated in Figure . After the addition of G4 c-MYC, the absorbance of the bands characteristic of all individual derivatives gradually decreases, but in some cases, in addition to hypochromism (24.3–48.4%), a bathochromic shift (Δλ = 0–16 nm) or subsequent hyperchromicity (0–7.1%) was observed (Figure , Table ). This indicates a different arrangement of phenazine derivatives with DNA. Spectrophotometric titration of ligands 5d, 6a, 8b, 9a, and 10ba with G4 c-MYC in Tris–HCl buffer (10 mM, pH 7.2) containing 100 mM KCl. Conditions: [L] = 6 μM; Titrant: [G4] = 1 mM, 10 mM Tris–HCl buffer (pH 7.2), 100 mM KCl. 2Spectral Effects for the Phenazine Ligands 5d, 6a, 8b, 9a, and 10ba Bound to G4 DNA and Parameters Determined Using the Benesi–Hildebrand MethodligandΔλmax [nm] hypochromicity [%] hyperchromicity [%] nKb (×105 M–1) 5d 1624.37.18.0 ± 0.1 6a 435.81.92.4 ± 0.1 8b 236.7 1.8 ± 0.2 9a 24.32.52.0 ± 0.2 10ba 148.4 9.4 ± 0.4aΔλ bathochromic shift.bHypochromicity and hyperchromicity were measured at λmax. The hypo- and hyperchromicity percentages were calculated using the following equations: %Hypo = [(A f – A b,min)/A f] × 100 and %Hyper = [(A b,max – A b,min)/A b,max] × 100, where A f, A b,min, and A b,max are the absorbances of free ligand, bound ligand with absorbance minimum, and bound ligand with absorbance maximum (excess of G4), respectively.cParameters for the interaction of ligands with c-MYC G-quadruplex determined using the Benesi–Hildebrand method in absorption titration experiments (K bbinding constant and nnumber of bound ligand molecules per G-quadruplex). Spectral Effects for the Phenazine Ligands 5d, 6a, 8b, 9a, and 10ba Bound to G4 DNA and Parameters Determined Using the Benesi–Hildebrand Method Δλ bathochromic shift. Hypochromicity and hyperchromicity were measured at λmax. The hypo- and hyperchromicity percentages were calculated using the following equations: %Hypo = [(A f – A b,min)/A f] × 100 and %Hyper = [(A b,max – A b,min)/A b,max] × 100, where A f, A b,min, and A b,max are the absorbances of free ligand, bound ligand with absorbance minimum, and bound ligand with absorbance maximum (excess of G4), respectively. Parameters for the interaction of ligands with c-MYC G-quadruplex determined using the Benesi–Hildebrand method in absorption titration experiments (K bbinding constant and nnumber of bound ligand molecules per G-quadruplex). Spectral changes in the form of hypochromicity >35% and red shifts >15 nm are characteristic of intercalary binding modes with long duplex DNA and terminal interactions with G-quadruplex terminal tetrads. Another spectral effect was observed in the literature for ligand: G4 interactions, which are the hypochromic effect with a subsequent hyperchromic effect and bathochromic shift. This effect was observed, for example, by Głuszyńska et al., who studied the interactions of carbazole derivatives with the same G-quadruplex c-MYC. This effect was explained by the two-step formation of the L: G4 complexat lower G4 concentrations, the positively charged ligand could electrostatically interact with the negatively charged phosphate groups on the G-quadruplex surface. Higher G4 concentrations were responsible for the hyperchromic effect and a change in the ligand-G4 end-stacking interaction. Spectral changes in the form of a hypochromic effect with no or a very small bathochromic shift are also encountered in the literature. Such an effect was observed, for example, during the interaction of the alkaloid coraline with a hybrid G-quadruplex formed on the telomeric sequence. The observed spectral effect was explained by a strong interaction resulting from the close arrangement of the planar ligand or intercalation between G-tetrads, which stabilized the studied G-quadruplex structure. Among the phenazine derivatives we have studied, the phenazin-2­(10H)-one 5d is distinguished by the presence of a carbonyl group in the aromatic system. The observed spectral result of the UV–vis titration experiment was a 24% hypochromism followed by a hyperchromic effect (7.1%) and a 16 nm bathochromic shift, which may indicate a two-step formation of the 5d:G4 DNA complex (Figure , Table ). The second ligand studied with a distinctive structure was derivative 10ba. The presence of an amide group in the structure of the compound increased the flat surface of the chromophore, which resulted in a completely different spectral course of the experiment. Practically the only observed effect was almost 50% hypochromism (Δλ = 1 nm), indicating that this ligand is more efficiently arranged on G-tetrads than other tested derivatives (Figure , Table ). For the remaining compounds 6a, 8b, and 9a, very similar spectral effects were observed: 24.3–36.7% hypochromism, no or a very small bathochromic shift (0–4 nm), and a hyperchromic effect (0–2.5%) (Figure , Table ). We believe that the minor differences in the observed spectral effects were due to the side substituents of the ligands but that their arrangement on the DNA is similar. In no case were sharp isosbestic points observed, indicating that the binding process is not a simple two-state binding equilibrium between free and bound ligands. We postulate that the observed hypochromism in the interaction of phenazine ligands with G4 c-MYC results from the unwinding of the studied DNA structure and that at higher G4/ligand ratios, we are dealing with single-stranded DNA, as confirmed by the titration experiment of the selected ligand 6a with c-MYC oligonucleotide (Figure S177) and the CD spectroscopy experiments (Figure ). The absorbance spectral data were quantitatively analyzed using the Benesi–Hildebrand (B–H) method to estimate binding affinities of the investigated ligands. In this case, K b values can only be estimated with the assumption that the stoichiometry of the formed ligand/G4 complex is 1:1. Binding constants calculated using eq , based on two independent UV–vis titration experiments, should be regarded as a nK b product (Figure S178). The results obtained indicated that the binding affinities of phenazine ligands to c-MYC DNA were on the order of 105 M–1. Compounds with an expanded chromophore surface area, including a carbonyl group (5d) and an amide group (10ba), exhibited stronger binding to G4 c-MYC, at 8.0 × 105 M–1 and 9.4 × 105 M–1, respectively. The remaining compounds with the same unexpanded chromophore exhibited very similar binding constants of 1.8–2.4 × 105 M–1. To determine the thermal effect of phenazine ligands on the DNA structure of the c-MYC G-quadruplex, a UV melting study was performed. In the experiments, the potassium ion concentration was reduced to 10 mM (10 mM KCl and 90 mM LiCl) to record the full melting profile in the absence and presence of 3 mol equiv of the compounds (Figure ). Normalized melting profiles of G-quadruplex c-MYC in the absence and presence of the phenazine ligands 5d, 6a, 8b, 9a, and 10ba. Conditions: [G4] = 2 μM, [L] = 6 μM, 10 mM sodium cacodylic buffer (pH 7.2), 90 mM LiCl, and 10 mM KCl. Data were collected at 293 nm. Typically, three replicate experiments were performed, and average values are reported within ±1.0 °C of each other. Melting temperatures (T m) were determined mathematically by the first derivative method (dA/dT vs T) from fitted sigmoidal melting curves. The UV melting data indicate a slight decrease and increase in the denaturation temperature of the G4 c-MYC complex with ligands within the range of −0.7 to 2.1. A slight stabilizing effect was observed for ligands 6a, 5d, 9a, and 8b, at 2.1, 1.9, 1.3, and 0.5 °C, respectively, while a very slight destabilizing effect of −0.7 °C was observed for ligand 10ba. Melting experiments allowed us to determine the thermodynamic parameters ΔH, ΔS, and ΔG over a wide temperature range (Table ). To determine the enthalpy and entropy contributions to the G4 c-MYC ligand interaction, van’t Hoff plots (ln K vs 1/T, eq ) were constructed. In most cases, the plots were linear, and the obtained ΔH and ΔS values were negative. The most unfavorable entropy associated with structural rigidity was calculated for ligands 10ba and 5d, −265.2 and −197.0 cal mol–1 K1, respectively, but this effect was compensated by enthalpically favorable processes, and the ΔH calculated for these ligands was −92.8 and −69.2 kcal mol–1, respectively. During the experiment, we added increasing amounts of the appropriate ligand to a pre-annealed solution of c-MYC G-quadruplex in a buffer containing 100 mM KCl and 10 mM Tris·HCl (pH 7.2), and after thorough mixing, we obtained a CD spectrum after 3 min of incubation. CD spectrum of a typical G-quadruplex with parallel structure is dominated by a strong positive band at 260 nm and a smaller negative band at 240 nm. Significant changes in the intensity of the DNA CD signal were observed under the influence of each of the tested ligands (Figure ). The addition of 1 mol equiv of ligands 9a and 10ba resulted in the fastest ellipticity reduction, by 34.7 and 51.2%, respectively. As can be seen in Figure , the addition of 5 and 7 equiv caused virtually no additional change in the CD band intensity in either case. 3 T m of G4 in the Absence and Presence of Ligands 5d, 6a, 8b, 9a, and 10ba, and Results of Thermodynamic Analysis of Denaturation Profiles T m ± SD [°C]ΔT m [°C]ΔH [kcal mol–1]ΔS[cal mol–1 K–1]ΔG (310 K) [kcal mol–1]G4 c-MYC 77.3 ± 0.5 –64.0 ± 2.1–182.4 ± 6.2–7.4 ± 0.2+5d 79.2 ± 0.7ΔT m = 1.9–69.2 ± 0.9–197.0 ± 3.2–8.2 ± 0.0+6a 79.4 ± 0.5ΔT m = 2.1–63.6 ± 3.0–179.8 ± 8.2–7.9 ± 0.5+8b 77.8 ± 1.8ΔT m = 0.5–53.0 ± 1.8–150.5 ± 5.3–6.3 ± 0.2+9a 78.6 ± 0.9ΔT m = 1.3–50.1 ± 5.5–141.4 ± 15.8–6.3 ± 0.6+10ba 76.6 ± 0.1ΔT m = −0.7–92.8 ± 7.1–265.2 ± 15.0–10.6 ± 0.8aConditions: 10 mM sodium cacodylic buffer (pH 7.2), 90 mM LiCl, 10 mM KCl, [G4] = 2 μM, [L] = 6 μM.bLiterature data: 76.8 °C, 25 mM KCl. T m of G4 in the Absence and Presence of Ligands 5d, 6a, 8b, 9a, and 10ba, and Results of Thermodynamic Analysis of Denaturation Profiles Conditions: 10 mM sodium cacodylic buffer (pH 7.2), 90 mM LiCl, 10 mM KCl, [G4] = 2 μM, [L] = 6 μM. Literature data: 76.8 °C, 25 mM KCl. CD spectra of c-MYC G-quadruplex (5 μM) with increasing concentration of compounds 5d, 6a, 8b, 9a, and 10ba in Tris–HCl buffer (10 mM, pH 7.2) containing 100 mM KCl. The tested ligands are achiral compounds and do not exhibit CD optical activity in solution. None of the tested compounds induced any signals in their long-wavelength absorption region (Figure ), which may indicate a similar mode of binding of the ligands to G4 c-MYC. The effect of the ligands on the reduction of the strong positive band at 265 nm, characteristic of a well-defined parallel structure, is therefore arranged in the following order: 8b (74.7%) > 10ba (72.5%) > 9a (61.2%) > 5d (49.4%) > 6a (41.2%). Using a variety of techniques, we demonstrated that phenazine derivatives interact with and destabilize a G-quadruplex formed on the human proto-oncogene c-MYC sequence. Dramatic changes in the CD spectra at 265 nm indicated the destruction of the G4 structure by all five ligands tested. The obtained stability constants of 1.8–9.4 × 105 M–1 were not very high, but at higher G4/ligand ratios, single-stranded DNA was observed, as confirmed by the CD spectra. It also appears that the observed dominant hypochromic effect in the interaction of phenazine derivatives with G4 of c-MYC is a spectral result of G-quadruplex unwinding. Among the tested compounds, phenazin-2­(10H)-one 5d stabilizes the tested G4 the most, as evidenced by the binding constant nKb = 8.0 × 105 M–1 and Gibbs free energy ΔG = −8.2 kcal mol–1, as well as lowering of the strong positive band at 265 nm characteristic for a well-defined parallel structure (49%). DNA melting analysis did not confirm such a destabilizing effect of ligands on the G4 DNA structure because the Gibbs free energy for free G4 c-MYC (ΔG = −7.4 kcal mol–1) did not change significantly in the presence of ligands (ΔG = from −6.3 to −10.6 kcal mol–1). However, this was a temperature experiment, and the absorbance (λmax) of the free ligands, monitored during the heating and cooling process, did not coincide, which may affect the obtained T m value and the appearance of the obtained temperature profiles (Figure S179). In summary, the phenazine scaffold is a highly desirable target for further research, as its ability to disrupt the stability of G4 DNA may have biomedical applications. The ability to synthesize asymmetric derivatives with the possibility of introducing up to four different substituents creates the possibility of finding derivatives that selectively distinguish individual G-quadruplex structures. While small organic molecules can distinguish antiparallel, hybrid, or parallel structures, there are no literature reports of ligands that distinguish individual parallel structures. Therefore, the synthesis of a new group of asymmetric compounds creates the opportunity to undertake research toward the selective discrimination of G-quadruplexes formed in gene promoter regions and thus to develop selective methods for G4 unfolding that could influence their biological role and therapeutic potential. Conclusion In this research, we have developed a synthetic protocol that provides chemo- and regioselective formation of phenazin-2­(10H)-one and 2-aminophenazine derivatives with high yields. The described method enables functionalization of the phenazine scaffold with a wide range of functional groups, thereby modulating the compound’s biological activity and spectroscopic properties. The applicability of the obtained representative compounds was investigated in detail through cell culture experiments, G4s stability studies, and spectroscopic measurements. For the investigated phenazine derivatives, detailed spectroscopic measurements were conducted, and fluorescence quantum yields were determined in chloroform and acetonitrile, indicating highly fluorescent compounds (Φ f > 0.10). The impact of the present substituents on spectroscopic properties was studied, which might find applications in future research on utilizing phenazine derivatives as sensors or fluorescent dyes. The cell culture experiments showed significant cytotoxicity of the investigated phenazine derivatives, where the most cytotoxic are N-alkyl phenazinium salts (12a and 12b) with IC50 = 6.4 μM and 11.4 μM, respectively, against the 4T1 cell line and IC50 = 3.7 μM and 9.8 μM, respectively, against the Caco-2 cell line. The phenazinones (5a and 5d) exhibit slightly lower effect with IC50 = 14.4 μM and 17.9 μM, respectively, against the 4T1 cell line and IC50 = 11.1 μM and 7.3 μM, respectively, against the Caco-2 cell line. For both of these compound groups, derivatives with 3–4 alkoxy groups (5d and 12a) are more cytotoxic than compounds with a tert-butyl substituent. Nevertheless, tert-butyl-substituted derivatives were significantly more selective against the cancer cell line 4T1 in comparison to the NMuMG normal cell line, with SI = 1.9 for 5a and 1.4 for 12b. Compounds 5d and 12a did not show any selectivity between the investigated cell lines; determined SI is close to 1 for both. The analysis of G4s stability for the c-MYC protooncogene sequence indicated a destabilizing effect of all investigated compounds (5d, 6a, 8b, 9a, and 10ba), where 8b and 10ba have the highest activity. The highest impact on G4s structure stability does not correlate with the highest cytotoxicity of the investigated derivatives, indicating that another mechanism of action is also involved, which will be investigated in future research. Methods General Information The NMR spectra of all investigated compounds were collected in chloroform-d or DMSO-d 6 solution using the following spectrometers: Bruker AVANCE III 300 MHz, JEOL JNM-ECZ400S 400 MHz, and JEOL JNM-ECZ600R 600 MHz. Structural assignments were supported by gCOSY, gHSQC, and gHMBC 2D NMR spectra analysis for selected compounds. The HRMS spectra were collected using a UHPLC-QTof system consisting of a Waters Acquity I-Class Plus coupled to a Waters Synapt XS mass spectrometer. Chromatographic separations were carried out using the Acquity UPLC BEH (bridged ethyl hybrid) C18 column. The Bruker Daltonics micrOTOF-Q II spectrometer was utilized for compounds unsuitable for reverse-phase chromatography. For absorption spectra measurements, the Hitachi U-3900H spectrometer, equipped with tungsten and deuterium lamps, was used. All emission spectra were collected using a Hitachi F-7000 spectrometer, equipped with a xenon lamp. For pH measurement, the ELMETRON pH-meter CP-411 was used with the ELMETRON EPS-1 probe. The compounds’ melting points were measured using an Axioscope A1 Pol polarized light microscope equipped with a LINKAM LTSE420 heating/cooling stage. The samples for melting point measurement were prepared by evaporation of DCM. The absorbance in the wells of the cell culture plates was measured with the BioTek EPOCH2 microplate reader. All compounds used in cytotoxicity assays are greater than 95% pure, as determined by HPLC and NMR analysis. For some of the investigated compounds (6a, 10ac, 10cc, and 10cd), the HPLC method cannot be utilized due to the compounds’ multiple protonation under chromatography conditions, resulting in a complex chromatogram that cannot be unequivocally interpreted. Starting Materials The 4,5-dialkoxy-2-nitroanilines used as starting substrates were obtained as described in the literature. Toluene used for the Buchwald–Hartwig amination was dried over sodium with benzophenone indicator, then distilled in an argon atmosphere and stored under argon over 4 Å molecular sieves. DMF for the synthesis was dried using the Innovative Technologies PureSolv Micro solvent purification system. Columns for chromatography were prepared using SILICYCLE SilicaFlash P60 silica gel (particle size 40–63 μm, 230–400 mesh). All other solvents and reagents were used as obtained from suppliers. Synthesis Protocols and Compounds Characterization The detailed description of all syntheses, including gram-scale synthesis and complete characterization of each compound, is contained in the Supporting Information. Cell Culture and In Vitro Cytotoxicity Assay The cells were grown to 70–80% confluence on surface-treated Petri dishes in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich, 4500 mg/L glucose, stable glutamine, and sodium bicarbonate, without sodium pyruvate) for all the examined cell lines. Cells were incubated at 37 °C in a CO2-enriched atmosphere (5% v/v) and high humidity. The murine mammary cancer cell line 4T1 (ATCC CRL-2539) was cultured in DMEM supplemented with 10% (v/v) fetal bovine serum (FBS, Sigma-Aldrich) and with the addition of penicillin–streptomycin mixture (Sigma-Aldrich, 10,000 units penicillin and 10 mg streptomycin/mL). The murine mammary normal cell line NMuMG (ATCC CRL-1636) was cultured with additional insulin supplementation (Sigma-Aldrich, human, 9.5–11.5 mg/mL). The Caco-2 cell line (ATCC: HTB-37) was cultured in DMEM supplemented with 20% (v/v) FBS and penicillin–streptomycin mixture. For cell passages, trypsin–EDTA solution (Sigma-Aldrich) was used. For all experiments, cells were seeded on 96-well plates and incubated for 24h before the addition of the compound solutions. Because of the compounds’ poor water-solubility, all experiments were conducted according to a nontypical, suitable protocol. For the preliminary tests, compounds were added in DMSO solution to a final concentration of 50 μM in wells. Maximal concentration was 50 μM because it is limited by the solubility of most of the investigated compounds in DMSO. In more detailed experiments, the IC50 value was determined by investigating concentrations of 0.1, 1, 3, 8, 15, 30, and 50 μM. In all assays, DMSO was used as a negative control, and doxorubicin at a final concentration of 10 μM was used as a positive control. The final concentration of DMSO in wells was 1% (v/v). After the addition of the investigated compound solutions, cells were incubated for 24 h and 48 h. Cell viability was determined by the MTT assay according to the literature protocol. To each well, 10 μL of MTT solution per 100 μL of culture media was added. The MTT solution (5 mg/1 mL PBS) was supplemented with menadione (to reach a final concentration of 20 μM in wells) and then sterilized by filtration through a 0.22 μm syringe filter. The cells were incubated with MTT for 4 h, and then the culture medium was removed and replaced with 150 μL of a methanol–DMSO mixture (v/v = 1:1). The absorbance was measured using an automatic plate reader at a wavelength of 570 nm (MTT-formazan) and 790 nm (background). All experiments were done in triplicate. IC50 values were determined with 95% confidence. LigandsG4 c-MYC Binding Study The quadruplex-forming deoxyribonucleotide with c-MYC sequence of 5′-TGAGGGTGGGTAGGGTGGGTAA-3′ (PDB id: 2L7 V) was purchased from Genomed (Poland) and was used without further purification. The strand concentration was determined at 260 nm at 85 °C using the extinction coefficient of 254,600 M–1 cm–1, as calculated from the published values of molar absorptivities of nucleotides. Before using, the oligonucleotide solution was heated at 85 °C for 5 min and subsequently allowed to cool slowly to room temperature, and then stored at 4 °C overnight. UV–Vis Absorption Titrations The absorption spectra were recorded on a Jasco spectrophotometer (Jasco, Tokyo, Japan) in the 220–650 nm range at 20 °C. All of the measurements were carried out using a 10 mm quartz cell. The experiments were carried out by adding small portions of 1 mM/strand of G4 c-MYC DNA solution to a cell containing 1000 μL of 6 μM ligand (10 mM Tris–HCl buffer (pH 7.2), 100 mM KCl). The titration experiment of ligand 6a with c-MYC oligonucleotide was performed in a similar manner without the addition of KCl. The G-quadruplex sample was prepared by heating the G-oligonucleotide solution in a 10 mM Tris - HCl buffer (pH 7.2) containing 100 mM KCl at 90 °C for 5 min, followed by slowly cooling to room temperature (3 h), and then storing at 4 °C overnight. Three minutes was the equilibration time after each DNA addition. Data from UV–vis binding studies were processed using the Benesi–Hildebrand transformation, which calculates the Kb value according to eq , assuming a 1:1 stoichiometry for the ligand/G4 complex. 1 cLAo−A=cLAo−Am+cL(Ao−Am)nKb×1cG4DNA where cL is the total concentration of ligand, Ao is the absorbance of ligand in the absence of G4 DNA, A is the absorbance recorded in the presence of added G4 DNA at the concentration of cG4 DNA, Am is the absorbance in the presence of added [cG4 DNA]­max, n is the number of bound ligand molecules per G-quadruplex, and K b is the binding constant. UV Melting Measurements In the melting studies, the prefolded G-quadruplex samples (2 μM/strand) were prepared in a 10 mM sodium cacodylate buffer (pH 7.2) containing 90 mM LiCl and 10 mM KCl. The melting profiles were recorded in the absence and presence of 3 equiv of ligands 5d, 6a, 8b, 9a, and 10ba every 1 °C during heating and cooling with 1 °C/min scan speed. Data were collected at 293 nm, and typically three replicate experiments were performed; average melting temperatures are reported with a standard deviation of ±1.0 °C. Melting points (T m) were determined mathematically using the first derivative method (dA/dT vs T). Thermal melting curves were used to calculate thermodynamic parameters for the formation of DNA G-quadruplex structures in the absence and presence of ligands. A curve-fitting procedure was used as previously described by Mergny and Lacroix. A two-state model was used to estimate the thermodynamic parameters, in which the folded G-quadruplex is in equilibrium with the unfolded chain. Molar free enthalpies ΔG and entropies ΔS were calculated according to the thermodynamic relationships (2) 2 ΔG=−RTln(K)=ΔH−TΔS where K is the equilibrium constant [K = f/(1 – f)], f is the fraction of folded oligonucleotide, R is the gas constant (8.314 J/mol K), T is the absolute temperature, ΔH is the reaction enthalpy, ΔS is the reaction entropy, and ΔG is the Gibbs free energy. Circular Dichroism Spectroscopy All CD experiments were performed using a Jasco J-810 spectropolarimeter (Jasco, Japan) equipped with a Peltier thermocontroller in 1 cm quartz cuvettes and averaged from 3 scans. CD spectra were registered in the spectral range from 220 to 600 nm with a 500 nm/min scan speed and a bandwidth of 1 nm. Measurements with prefolded G-quadruplex (5 μM/strand) were performed at 25 °C in a 10 mM Tris - HCl buffer (pH 7.2) containing 100 mM KCl. Ligands were added to the G4 DNA solution at increasing concentrations from 1 to 7 mol equiv. The equilibrium time after each addition of 5d, 6a, 8b, 9a, and 10ba was 3 min. Supplementary Material